Safety of the HIV Vaccine 732462 in HIV Infected Subjects Aged 18 to 55 Years Old

NCT00814762 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

41

Enrollment

INDUSTRY

Sponsor class

Conditions

AIDS

Interventions

BIOLOGICAL: HIV Vaccine 732462
BIOLOGICAL: Placebo vaccine

Sponsor

GlaxoSmithKline